| References |
|
|
Aasen T,
Raya A,
Barrero MJ et al.
(2008)
Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.
Nature Biotechnology
26:
1276–1284.
|
|
|
Alison MR,
Lim SM and
Nicholson LJ
(2011)
Cancer stem cells: problems for therapy?
Journal of Pathology
223:
147–161.
|
|
|
Ambasudhan R,
Talantova M,
Coleman R et al.
(2011)
Direct reprogramming of adult human fibroblasts to functional neurons under defined conditions.
Cell Stem Cell
9:
113–118.
|
|
|
Anastasia L,
Pelissero G,
Venerando B and
Tettamanti G
(2010)
Cell reprogramming: expectations and challenges for chemistry in stem cell biology and regenerative medicine.
Cell Death & Differentiation
17:
1230–1237.
|
|
|
Aoi T,
Yae K,
Nakagawa M et al.
(2008)
Generation of pluripotent stem cells from adult mouse liver and stomach cells.
Science
321:
699–702.
|
|
|
Bonnet D and
Dick JE
(1997)
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.
Nature Medicine
3:
730–737.
|
|
|
Calcagno AM,
Salcido CD,
Gillet JP et al.
(2010)
Prolonged drug selection of breast cancer cells and enrichment of cancer stem cell characteristics.
Journal of National Cancer Institute
102:
1637–1652.
|
|
|
Chen FH,
Rousche KT and
Tuan RS
(2006)
Technology Insight: adult stem cells in cartilage regeneration and tissue engineering.
Nature Clinical Practice Rheumatology
2:
373–382.
|
|
|
Cherry AB and
Daley GQ
(2012)
Reprogramming cellular identity for regenerative medicine.
Cell
148:
1110–1122.
|
|
|
Chou BK,
Mali P,
Huang X et al.
(2011)
Efficient human iPS cell derivation by a non‐integrating plasmid from blood cells with unique epigenetic and gene expression signatures.
Cell Research
21:
518–529.
|
|
|
Clarke MF,
Dick JE,
Dirks PB et al.
(2006)
Cancer stem cells – perspectives on current status and future directions: AACR Workshop on cancer stem cells.
Cancer Research
66:
9339–9344.
|
|
|
Cohen DE and
Melton D
(2011)
Turning straw into gold: directing cell fate for regenerative medicine.
Nature Reviews Genetics
12:
243–252.
|
|
|
Dadon‐Nachum M,
Sadan O,
Srug OI,
Melamed E and
Offen D
(2011)
Differentiated mesenchymal stem cells for sciatic nerve injury.
Stem Cell Reviews
7:
664–671.
|
|
|
book
Durand RE
(1999)
"Cell growth and kinetics in multicell spheroids"
In: Studzinski GP (ed.)
Cell Growth, Differentiation and Senescence – A Practical Approach,
pp. 61–79.
Oxford: Oxford University Press.
|
|
|
Efe JA,
Hilcove S,
Kim J et al.
(2011)
Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy.
Nature Cell Biology
13:
215–222.
|
|
|
Eminli S,
Utikal J,
Arnold K,
Jaenisch R and
Hochedlinger K
(2008)
Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression.
Stem Cells
26:
2467–2474.
|
|
|
Endo T
(1992)
SV40 large T inhibits myogenic differentiation partially through inducing c‐jun.
Journal of Biochemistry
112:
321–329.
|
|
|
Fu L,
Zhu L,
Huang Y et al.
(2008)
Derivation of neural stem cells from mesenchymal stemcells: evidence for a bipotential stem cell population.
Stem Cells Development
17:
1109–1121.
|
|
|
Ghiaur G,
Gerber JM,
Matsui W and
Jones RJ
(2012)
Cancer stem cells: relevance to clinical transplantation.
Current Opinion in Oncology
24:
170–175.
|
|
|
Giorgetti A,
Montserrat N,
Aasen T et al.
(2009)
Generation of induced pluripotent stem cells from human cord blood using OCT4 and SOX2.
Cell Stem Cell
5:
353–357.
|
|
|
Greco SJ,
Zhou C,
Ye JH and
Rameshwar P
(2007)
An interdisciplinary approach and characterization of neuronal cells transdifferentiated from human mesenchymal stem cells.
Stem Cells Development
16:
811–826.
|
|
|
Greve B,
Kelsch R,
Spaniol K,
Eich HT and
Gotte M
(2012)
Flow cytometry in cancer stem cell analysis and separation.
Cytometry Part A
81:
284–293.
|
|
|
Grskovic M,
Javaherian A,
Strulovici B and
Daley GQ
(2011)
Induced pluripotent stem cells – opportunities for disease modelling and drug discovery.
Nature Reviews Drug Discovery
10:
915–929.
|
|
|
Haase A,
Olmer R,
Schwanke K et al.
(2009)
Generation of induced pluripotent stem cells from human cord blood.
Cell Stem Cell
5:
434–441.
|
|
|
Hanna J,
Markoulaki S,
Schorderet P et al.
(2008)
Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.
Cell
133:
250–264.
|
|
|
Hsu YC and
Fuchs E
(2012)
A family business: stem cell progeny join the niche to regulate homeostasis.
Nature Reviews Molecular Cell Biology
13:
103–114.
|
|
|
Huangfu D,
Maehr R,
Guo W et al.
(2008)
Induction of pluripotent stem cells by defined factors is greatly improved by small‐molecule compounds.
Nature Biotechnology
26:
795–797.
|
|
|
Ieda M,
Fu JD,
Delgado‐Olguin P et al.
(2010)
Direct reprogramming of fibroblasts into functional cardiomyocytes by defined factors.
Cell
142:
375–386.
|
|
|
Iliopoulos D,
Hirsch HA,
Wang G and
Struhl K
(2011)
Inducible formation of breast cancer stem cells and their dynamic equilibrium with non‐stem cancer cells via IL6 secretion.
Proceedings of the National Academy of Sciences of the USA
108:
1397–1402.
|
|
|
Jopling C,
Boue S and
Izpisua Belmonte JC
(2011)
Dedifferentiation, transdifferentiation and reprogramming: three routes to regeneration.
Nature Reviews Molecular Cell Biology
12:
79–89.
|
|
|
Kaushansky K
(2006)
Lineage‐specific hematopoietic growth factors.
New England Journal of Medicine
354:
2034–2045.
|
|
|
Kemp KC,
Hows J and
Donaldson C
(2005)
Bone marrow‐derived mesenchymal stem cells.
Leukemia & Lymphoma
46:
1531–1544.
|
|
|
Koh MB and
Suck G
(2012)
Cell therapy: promise fulfilled?
Biologicals
40:
214–217.
|
|
|
Kulterer B,
Friedl G,
Jandrositz A et al.
(2007)
Gene expression profiling of human mesenchymal stem cells derived from bone marrow during expansion and osteoblast differentiation.
BMC Genomics
8:
70.
|
|
|
van Laake LW,
Hassink R,
Doevendans PA and
Mummery C
(2006)
Heart repair and stem cells.
Journal of Physiology
577:
467–478.
|
|
|
Lapidot T,
Sirard C,
Vormoor J et al.
(1994)
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice.
Nature
367:
645–648.
|
|
|
Laslett AL,
Grimmond S,
Gardiner B et al.
(2007)
Transcriptional analysis of early lineage commitment in human embryonic stem cells.
BMC Developmental Biology
7:
12.
|
|
|
Lee JY,
Zhou Z,
Taub PJ et al.
(2011)
BMP‐12 treatment of adult mesenchymal stem cells in vitro augments tendon‐like tissue formation and defect repair in vivo.
PLoS ONE
6:
e17531.
|
|
|
Li W,
Wei W,
Zhu S et al.
(2009)
Generation of rat and human induced pluripotent stem cells by combining genetic reprogramming and chemical inhibitors.
Cell Stem Cell
4:
16–19.
|
|
|
Lieubeau‐Teillet B,
Rak J,
Jothy S et al.
(1998)
von Hippel‐Lindau gene‐mediated growth suppression and induction of differentiation in renal cell carcinoma cells grown as multicellular tumor spheroids.
Cancer Research
58:
4957–4962.
|
|
|
Liu T,
Zou G,
Gao Y et al.
(2012)
High efficiency of reprogramming CD34+ cells derived from human amniotic fluid into induced pluripotent stem cells with Oct4.
Stem Cells Development [Epub ahead of print].
|
|
|
Ma Y,
Poisson L,
Sanchez‐Schmitz G et al.
(2010)
Assessing the immunopotency of Toll‐like receptor agonists in an in vitro tissue‐engineered immunological model.
Immunology
130:
374–387.
|
|
|
Makino S,
Fukuda K,
Miyoshi S et al.
(1999)
Cardiomyocytes can be generated from marrow stromal cells in vitro.
Journal of Clinical Investigation
103:
697–705.
|
|
|
Mao JJ,
Giannobile WV,
Helms JA et al.
(2006)
Craniofacial tissue engineering by stem cells.
Journal of Dental Research
85:
966–979.
|
|
|
Meng X,
Neises A,
Su RJ et al.
(2012)
Efficient reprogramming of human cord blood CD34+ cells into induced pluripotent stem cells with OCT4 and SOX2 alone.
Molecular Therapy
20:
408–416.
|
|
|
Minguell JJ,
Erices A and
Conget P
(2001)
Mesenchymal stem cells.
Experimental Biology and Medicine (Maywood)
226:
507–520.
|
|
|
Mosna F,
Sensebe L and
Krampera M
(2010)
Human bone marrow and adipose tissue mesenchymal stem cells: a user's guide.
Stem Cells Development
19:
1449–1470.
|
|
|
Mukherjee AB,
Murty LC and
Chou JY
(1993)
Differentiation and uteroglobin gene expression by novel rabbit endometrial cell lines.
Molecular Cell Endocrinology
94:
R15–R22.
|
|
|
Nagata S,
Toyoda M,
Yamaguchi S et al.
(2009)
Efficient reprogramming of human and mouse primary extra‐embryonic cells to pluripotent stem cells.
Genes to Cells
14:
1395–1404.
|
|
|
Nakagawa M,
Koyanagi M,
Tanabe K et al.
(2008)
Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
Nature Biotechnology
26:
101–106.
|
|
|
Narita Y,
Yamawaki A,
Kagami H,
Ueda M and
Ueda Y
(2008)
Effects of transforming growth factor‐beta 1 and ascorbic acid on differentiation of human bone‐marrow‐derived mesenchymal stem cells into smooth muscle cell lineage.
Cell Tissue Research
333:
449–459.
|
|
|
Nguyen LV,
Vanner R,
Dirks P and
Eaves CJ
(2012)
Cancer stem cells: an evolving concept.
Nature Reviews Cancer
12:
133–143.
|
|
|
Nicolini FE,
Holyoake TL and
Cashman JD
(1999)
Unique differentiation programs of human fetal liver stem cells shown both in vitro and in vivo in NOD/SCID mice.
Blood
94:
2686–2695.
|
|
|
O'Brien CA,
Kreso A and
Jamieson CH
(2010)
Cancer stem cells and self‐renewal.
Clinical Cancer Research
16:
3113–3120.
|
|
|
Papapetrou EP and
Sadelain M
(2011)
Generation of transgene‐free human induced pluripotent stem cells with an excisable single polycistronic vector.
Nature Protocol
6:
1251–1273.
|
|
|
Patru C,
Romao L,
Varlet P et al.
(2010)
CD133, CD15/SSEA‐1, CD34 or side populations do not resume tumor‐initiating properties of long‐term cultured cancer stem cells from human malignant glio‐neuronal tumors.
BMC Cancer
10:
66.
|
|
|
Pietras A
(2011)
Cancer stem cells in tumor heterogeneity.
Advances in Cancer Research
112:
255–281.
|
|
|
Pittenger MF,
Mackay AM,
Beck SC et al.
(1999)
Multilineage potential of adult human mesenchymal stem cells.
Science
284:
143–147.
|
|
|
Polak JM and
Bishop AE
(2006)
Stem cells and tissue engineering: past, present, and future.
Annals of the New York Academy of Sciences
1068:
352–366.
|
|
|
Pournasr B,
Khaloughi K,
Salekdeh GH et al.
(2011)
Concise review: alchemy of biology: generating desired cell types from abundant and accessible cells.
Stem Cells
29:
1933–1941.
|
|
|
Randolph GJ,
Beaulieu S,
Lebecque S,
Steinman RM and
Muller WA
(1998)
Differentiation of monocytes into dendritic cells in a model of transendothelial trafficking.
Science
282:
480–483.
|
|
|
Robinton DA and
Daley GQ
(2012)
The promise of induced pluripotent stem cells in research and therapy.
Nature
481:
295–305.
|
|
|
Rubin CS,
Hirsch A,
Fung C and
Rosen OM
(1978)
Development of hormone receptors and hormonal responsiveness in vitro. Insulin receptors and insulin sensitivity in the preadipocyte and adipocyte forms of 3T3‐L1 cells.
Journal of Biological Chemistry
253:
7570–7578.
|
|
|
Sato N and
Brivanlou AH
(2006)
Manipulation of self‐renewal in human embryonic stem cells through a novel pharmacological GSK‐3 inhibitor.
Methods in Molecular Biology
331:
115–128.
|
|
|
Scaffidi P and
Misteli T
(2011)
In vitro generation of human cells with cancer stem cell properties.
Nature Cell Biology
13:
1051–1061.
|
|
|
Schemionek M,
Elling C,
Steidl U et al.
(2010)
BCR‐ABL enhances differentiation of long‐term repopulating hematopoietic stem cells.
Blood
115:
3185–3195.
|
|
|
Seki T,
Yuasa S and
Fukuda K
(2012)
Generation of induced pluripotent stem cells from a small amount of human peripheral blood using a combination of activated T cells and Sendai virus.
Nature Protocol
7:
718–728.
|
|
|
Shih CC,
Hu MC,
Hu J,
Medeiros J and
Forman SJ
(1999)
Long‐term ex vivo maintenance and expansion of transplantable human hematopoietic stem cells.
Blood
94:
1623–1636.
|
|
|
Solchaga LA,
Penick KJ and
Welter JF
(2011)
Chondrogenic differentiation of bone marrow‐derived mesenchymal stem cells: tips and tricks.
Methods inMolecular Biology
698:
253–278.
|
|
|
Stadtfeld M,
Brennand K and
Hochedlinger K
(2008)
Reprogramming of pancreatic beta cells into induced pluripotent stem cells.
Current Biology
18:
890–894.
|
|
|
Studzinski GP and
Brelvi ZS
(1987)
Changes in proto‐oncogene expression associated with reversal of macrophage‐like differentiation of HL 60 cells.
Journal of National Cancer Institute
79:
67–76.
|
|
|
Studzinski GP,
Gierthy JF and
Cholon JJ
(1973)
An autoradiographic screening test for mycoplasmal contamination of mammalian cell cultures.
In Vitro
8:
466–472.
|
|
|
Suda T,
Takubo K and
Semenza GL
(2011)
Metabolic regulation of hematopoietic stem cells in the hypoxic niche.
Cell Stem Cell
9:
298–310.
|
|
|
Sun N,
Panetta NJ,
Gupta DM et al.
(2009)
Feeder‐free derivation of induced pluripotent stem cells from adult human adipose stem cells.
Proceedings of the National Academy of Sciences of the USA
106:
15720–15725.
|
|
|
Takahashi K,
Tanabe K,
Ohnuki M et al.
(2007)
Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
Cell
131:
861–872.
|
|
|
Takahashi K and
Yamanaka S
(2006)
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
Cell
126:
663–676.
|
|
|
Tang C and
Drukker M
(2011)
Potential barriers to therapeutics utilizing pluripotent cell derivatives: intrinsic immunogenicity of in vitro maintained and matured populations.
Seminars in Immunopathology
33:
563–572.
|
|
|
Titushkin I,
Sun S,
Shin J and
Cho M
(2010)
Physicochemical control of adult stem cell differentiation: shedding light on potential molecular mechanisms.
Journal of Biomedicine and Biotechnology
2010:
743476.
|
|
|
Vermeulen L,
de Sousa e Melo F,
Richel DJ and
Medema JP
(2012)
The developing cancer stem‐cell model: clinical challenges and opportunities.
Lancet Oncology
13:
e83–e89.
|
|
|
Woods NB,
Parker AS,
Moraghebi R et al.
(2011)
Brief report: efficient generation of hematopoietic precursors and progenitors from human pluripotent stem cell lines.
Stem Cells
29:
1158–1164.
|
|
|
Wu JQ,
Seay M,
Schulz VP et al.
(2012)
Tcf7 is an important regulator of the switch of self‐renewal and differentiation in a multipotential hematopoietic cell line.
PLoS Genetics
8:
e1002565.
|
|
|
Yu J,
Vodyanik MA,
Smuga‐Otto K et al.
(2007)
Induced pluripotent stem cell lines derived from human somatic cells.
Science
318:
1917–1920.
|
|
|
Zhang F,
Godyn JJ,
Uskokovic M,
Binderup L and
Studzinski GP
(1994)
Monocytic differentiation of HL60 cells induced by potent analogs of vitamin D3 precedes the G1/G0 phase cell cycle block.
Cell Proliferation
27:
643–654.
|
|
|
Zhou H,
Wu S,
Joo JY et al.
(2009)
Generation of induced pluripotent stem cells using recombinant proteins.
Cell Stem Cell
4:
381–384.
|
|
|
Zhu S,
Wei W and
Ding S
(2011)
Chemical strategies for stem cell biology and regenerative medicine.
Annual Review of Biomedicine Engineering
13:
73–90.
|
| Further Reading |
|
|
Akala OO and
Clarke MF
(2006)
Hematopoietic stem cell self‐renewal.
Current Opinion in Genetics and Development
16:
496–501.
|
|
|
Arwert EN,
Hoste E and
Watt FM
(2012)
Epithelial stem cells, wound healing and cancer.
Nature Reviews Cancer
12:
170–180.
|
|
|
Bautch VL
(2011)
Stem cells and the vasculature.
Nature Medicine
17:
1437–1443.
|
|
|
Brzoska E,
Ciemerych MA,
Przewozniak M and
Zimowska M
(2011)
Regulation of muscle stem cells activation: the role of growth factors and extracellular matrix.
Vitamins & Hormones
87:
239–276.
|
|
|
Coffman FD and
Studzinski GP
(1999)
Differentiation‐related mechanisms which suppress DNA replication.
Experimental Cell Research
248:
58–73.
|
|
|
Dado D,
Sagi M,
Levenberg S and
Zemel A
(2012)
Mechanical control of stem cell differentiation.
Regenerative Medicine
7:
101–116.
|
|
|
Fiorina P,
Voltarelli J and
Zavazava N
(2011)
Immunological applications of stem cells in type 1 diabetes.
Endocrine Reviews
32:
725–754.
|
|
|
Huang JK,
Fancy SP,
Zhao C et al.
(2011)
Myelin regeneration in multiple sclerosis: targeting endogenous stem cells.
Neurotherapeutics
8:
650–658.
|
|
|
Jordan NV,
Johnson GL and
Abell AN
(2011)
Tracking the intermediate stages of epithelial‐mesenchymal transition in epithelial stem cells and cancer.
Cell Cycle
10:
2865–2873.
|
|
|
Mali P and
Cheng L
(2012)
Concise review: human cell engineering: cellular reprogramming and genome editing.
Stem Cells
30:
75–81.
|
|
|
Peng LH,
Fung KP,
Leung PC and
Gao JQ
(2011)
Genetically manipulated adult stem cells for wound healing.
Drug Discovery Today
16:
957–966.
|
|
|
Sharma S,
Raju R,
Sui S and
Hu WS
(2011)
Stem cell culture engineering – process scale up and beyond.
Biotechnology Journal
6:
1317–1329.
|
